Hide metadata

dc.contributor.authorSelli, Anders L.
dc.contributor.authorGhasemi, Mohammadreza
dc.contributor.authorWatters, Taylor
dc.contributor.authorBurton, Francis
dc.contributor.authorSmith, Godfrey
dc.contributor.authorDietrichs, Erik S.
dc.date.accessioned2023-10-31T06:03:12Z
dc.date.available2023-10-31T06:03:12Z
dc.date.issued2023
dc.identifier.citationScandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2023 Oct 25;31(1):61
dc.identifier.urihttp://hdl.handle.net/10852/105625
dc.description.abstractBackground Accidental hypothermia, recognized by core temperature below 35 °C, is a lethal condition with a mortality rate up to 25%. Hypothermia-induced cardiac dysfunction causing increased total peripheral resistance and reduced cardiac output contributes to the high mortality rate in this patient group. Recent studies, in vivo and in vitro, have suggested levosimendan, milrinone and isoprenaline as inotropic treatment strategies in this patient group. However, these drugs may pose increased risk of ventricular arrhythmias during hypothermia. Our aim was therefore to describe the effects of levosimendan, milrinone and isoprenaline on the action potential in human cardiomyocytes during hypothermia. Methods Using an experimental in vitro-design, levosimendan, milrinone and isoprenaline were incubated with iCell2 hiPSC-derived cardiomyocytes and cellular action potential waveforms and contraction were recorded from monolayers of cultured cells. Experiments were conducted at temperatures from 37 °C down to 26 °C. One-way repeated measures ANOVA was performed to evaluate differences from baseline recordings and one-way ANOVA was performed to evaluate differences between drugs, untreated control and between drug concentrations at the specific temperatures. Results Milrinone and isoprenaline both significantly increases action potential triangulation during hypothermia, and thereby the risk of ventricular arrhythmias. Levosimendan, however, does not increase triangulation and the contractile properties also remain preserved during hypothermia down to 26 °C. Conclusions Levosimendan remains a promising candidate drug for inotropic treatment of hypothermic patients as it possesses ability to treat hypothermia-induced cardiac dysfunction and no increased risk of ventricular arrhythmias is detected. Milrinone and isoprenaline, on the other hand, appears more dangerous in the hypothermic setting.
dc.language.isoeng
dc.rightsThe Authors; licensee BioMed Central Ltd.
dc.rightsNorwegian Air Ambulance Foundation
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleProarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study
dc.typeJournal article
dc.date.updated2023-10-31T06:03:12Z
dc.creator.authorSelli, Anders L.
dc.creator.authorGhasemi, Mohammadreza
dc.creator.authorWatters, Taylor
dc.creator.authorBurton, Francis
dc.creator.authorSmith, Godfrey
dc.creator.authorDietrichs, Erik S.
dc.identifier.cristin2188660
dc.identifier.doihttps://doi.org/10.1186/s13049-023-01134-5
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.type.versionPublishedVersion
cristin.articleid61


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International